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Endovascular procedures are becoming the standard type of care for the man-
agement of hemodialysis vascular access dysfunction. As with any type of med-
ical procedure, these techniques can result in procedure-related complications,
although the expected number of complications is low. The clinical extent of these
complications varies from case to case. Management of these cases depends on
the clinical presentation. Major complications such as vein rupture, arterial
embolism, remote site bleeding or hematoma, symptomatic pulmonary embolism
and puncture site complications necessitating treatment require major therapy.
Minor complications such as non-flow compromising small puncture site
hematoma or pseudoaneurysms require little or no therapy. It is essential that the
interventionist be prepared to manage these complications appropriately when
they arise.
enous stenosis and its end result, thrombosis, are common when synthetic
grafts are used for hemodialysis (HD) access (1, 2). Endovascular
procedures are becoming the standard type of care for the management
of these problems. In general, a procedure-related complication is defined as an
adverse event that occurs as a result of the procedure. The rate at which these compli-
cations can be expected to occur varies based on each individual procedure. The actual
rate observed can be affected by external factors such as the manner in which the
procedure is performed. A procedure with an excessive complication rate suggests the
need for critical evaluation of the technique and procedure. The interventionist
performing the basic procedure must be prepared to manage any complications as they
occur (3, 4). The purpose of this article is to discuss the complications that can occur
during the treatment of vascular access problems requiring additional endovascular
therapy for management.
MATERIALS AND METHODS
A retrospective review of 3,430 failing dialysis accesses (graft : native = 1,662 :
1,768), between April 1997 and June 2004, revealed 221 (6.4%) complications
occurred during percutaneous transluminal angioplasty (PTA). In dysfunction of the
3,430 accesses, there was 708 thrombosed HD access grafts. In 606 of 708 the
thrombosed grafts, percutaneous thrombi aspiration with a Desilets-Hoffman sheath
(COOK, Bloomington, IN, USA) and balloon dilatation of the venous anastomosis and
mobilization of the arterial plug using a Forgarty catheter (Baxter, Santa Ana, CA,
USA) maneuver were used (5). In 102 of the thrombosed grafts, the urokinase
thrombolysis technique (urokinase 20,000 300,000 IU) was used and then a balloon
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Vangioplasty was performed (6). Three hundred and ten
stent deployments (peripheral vein : central vein = 99 :
211) were performed. When stenoses of the native veins
occured, thrombolysis was performed with urokinase, and
was followed by PTA. When a complete obstruction of
central veins occured, guide wire was passed and then
ballooning and stenting was performed using urokinase.
Details of the procedure-related complications (n=221) are
summarized in Table 1. The reported complications were
identified clinically or angiographically while the patient
was still undergoing the procedure. Most of complications
were treated at the same time, allowing for the completion
of the procedure. Records of delayed complications such as
prolonged bleeding or reopening of the puncture sites after
the patient was discharged, were not available. Due to the
diverse nature of the complications, each type and their
treatment will be described separately. Definitions apply to
the treatment of immediate complications allowing for the
completion of the recanalization of the HD access dysfunc-
tion.
COMPLICATIONS AND MANAGEMENT
All events related to complications that arose from access
intervention and occurred during the procedure. Major
complications were defined as complications; 1) requiring
therapy and minor hospitalization (< 48 hours), 2) requir-
ing major therapy, unplanned increase in level of care and
prolonged hospitalization (> 48 hours), 3) permanent
adverse sequelae, or 4) death. These include vascular
perforation or rupture, arterial embolization, remote site
bleeding or hematoma, death, symptomatic pulmonary
embolism and puncture site complications necessitating
treatment. Minor complications such as non-flow compro-
mising small puncture site hematoma or pseudoaneurysms
were defined as incidents with 1) no consequences and no
additional therapy, 2) nominal therapy and no
consequences, including overnight admission for observa-
tion only (1).
Vein Rupture-Extravasation Following PTA 
Vein rupture is a common complication of PTA.
Ruptures following angioplasty have been reported to
occur in 2.1 to 20% of patients (7, 8). Both acute and
delayed venous ruptures have been reported. Vein
ruptures typically occur as a complication of venous
angioplasty used to correct the stenosis in synthetic grafts
and autologous fistulas. Contrast extravasation can be of
minor significance, causing a small hematoma and requir-
ing no corrective action, or it can be more serious, causing
a tear in the vein wall and affecting flow within the graft
(9). Treatment of venous ruptures is aimed at minimizing
hemorrhage and preserving access function. In most cases
observation alone or repeated, prolonged inflation of the
angioplasty balloon can control contrast extravasation,
stop the hemorrhage, and preserve access function. In
more severe tears and ruptures of the vein, endovascular
stents have been successfully used to stop bleeding and
preserve the access (9). Sometimes hemorrhage in the
ruptured vein can be controlled by intentional graft
thrombosis, with placement of a temporary hemodialysis
catheter, followed by percutaneous thrombolysis of the
graft. With ruptures of the vein surgical intervention is
rarely necessary, although graft loss may occur, and a new
vascular access may be required.
In the authors’ hospital, PTA was used to treat greater
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Table 1. Complications and Treatments Occurring During Hemodialysis Access Recanalization
Complications No of Pts Treatment
Venous/ venous anastomotic rupture 158 Ballooning (142), stent (14), OP (2)
Arterial emboli 19 Retracting emboli (17), OP (1), conservative treatment (1)
Venous/Intragraft dissection 11 Ballooning (11)
Graft extravasation 10 Digital pressure/elastic bandage / balloon tamponade (10)
Hematoma at puncture site 6 Elastic bandage (6)
Arterial rupture 4 Ballooning (4)
Balloon fragmentation 3 OP (3)
Symptomatic pulmonary embolism 2 Conservative treatment (2)
Cardiac arrest 2 Death (1), conservative treatment (1)
Displacement of stent 2 Snaring (1), conservative treatment (1)
Septic embolism 1 OP (1)
Arterial dissection 1 Conservative treatment (1)
Iatrogenic femoral arteriovenous fistula 1 Conservative treatment (1)
Guide wire fracture 1 OP (1)
Note. No of Pts = number of patients, OP = operationthan 50% of stenoses involving segments via an appropri-
ate size vascular sheath. An angioplasty balloon 4 16 mm
in diameter over a 0.035 inch guidewire was inflated to
12 24 atm. All cases involving a rupture (158/3,430,
4.6%) described here were identified as contrast extrava-
sation from the angioplasty site, which resulted in severe
stasis in the graft and outflow. In order to manage venous
ruptures, the sites where the rupture occurred were
compressed manually for 3 5 minutes, or flow was
blocked with a balloon catheter for 3 5 minutes (10) (Fig.
1). Persistent extravasations accompanied by cessation of
flow, after prolonged balloon tamponade (3 5 min) were
managed by deploying uncovered metallic stents (11) (Fig.
2) . Stent placements are thought to control ruptures by
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Fig. 1. 58-year-old woman with a left
radiocephalic fistula.
A. Diffuse stenosis of the distal cephalic
vein is shown.
B. Contrast extravasation after balloon-
ing is shown at the proximal diffuse
stenotic lesion.
C. Blood flow is blocked by a balloon
catheter for five minutes.
D. Postprocedural angiography shows
restoration of the lumen.
AB
CDimproving graft outflow, which then decreases pressure
locally at the site of rupture. The stent also may work to
flatten the intimal flap, which was raised during
angioplasty, and allow for closure. Stents ranged in size
from 6 40 mm to 10 60 mm. Selection was made on a
case by case basis based on the patient’s vessel size. All
stents were introduced to the access using an appropriate
size (7 8 Fr) vascular sheath which was advanced through
the venous anastomosis and outflow into the central vein.
Each stent was subsequently dilated with the use of an
angioplasty balloon of the same diameter. A total of 14
(graft anastomosis : native peripheral vein = 13 : 1)
uncovered metallic stents were deployed to treat the
vascular ruptures. Immediate angiographic evaluation was
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Fig. 2. 47-year-old woman with a left
radiobasilic graft.
A. Diffuse tight stenosis is shown at the
venous anastomosis (arrows).
B. Extravasation after ballooning causing
vein rupture.
C. Blood flow was blocked by a balloon
catheter for five minutes. However,
fistulography shows continuous extrava-
sation and persistent residual stenosis by
severe tears and ruptures of the vein.
Endovascular stents were successfully
used to stop the bleeding and preserve
the access.
D. Follow-up angiography shows good
patency of the lumen and no leakage.
AB
CDperformed following stent deployment to confirm proper
position and to evaluate whether there was any persistent
extravasation or pseudoaneurysm formation. There were
no hemodynamically significant complications following
the deployment of the stents. Two patients underwent
surgery: one had uncontrollable bleeding, and the other
had nerve compression symptoms as a result of a
hematoma. The Dialysis Outcomes Quality Initiative
(DOQI) guidelines recommend stent placement to be
reserved for patients with limited residual access sites that
have a contraindication to surgery or in whom the lesion is
surgically inaccessible that fail PTA (two PTAs in a 3-
month period).
Arterial Emboli
Arterial embolism is a well-known complication of
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Fig. 3. 68-year-old woman with a right
upper arm brachiobasilic graft.
A. Abrupt cutoff in the ulnar artery means
an arterial embolus.
B. 7F Desilet-Hoffman sheath was
advanced through the artery near the
embolus.
C. Angiography after retraction of the
embolus in the sheath demonstrates a
successful retrieval resulting in the
restoration of the arterial lumen.
D. The retracted embolus is shown.
AB
CDpercutaneous dialysis graft thrombolysis. In pulse spray
techniques, overly vigorous flushing of the catheters
inserted into the clotted grafts may cause an acute increase
in pressure within the graft, leading to reflux of the clot
into the artery and peripheral embolism. Passing catheters
and guide wires across and beyond the arterial anastomosis
may also cause arterial embolisms, as may maceration of
the arterial plug. The incidence of arterial emboli following
percutaneous dialysis graft thrombolysis has been reported
to be in the range of between 0% and 6.3% (12).
Management of arterial emboli hinges upon whether they
are symptomatic or asymptomatic. Asymptomatic emboli
may not require any specific treatment. In one series,
asymptomatic embli following surgical graft thrombectomy
were not treated, resolved without further intervention,
and did not result in any ischemic symptoms for a mean of
one year following the procedure (13). These findings, if
applied to percutaneous intervention, support a policy of
observation for asymptomatic arterial emboli.
Symptomatic emboli causing hand ischemia or diminished
post-procedure pulses clearly require treatment. Available
options have traditionally included surgical thrombectomy,
infusion of thrombolytic agents such as urokinase, and
mechanical mobilization (pulling the embolus back into the
graft) with a balloon.
In our cases, arterial emboli were observed in 19/708
(2.7%) of the recanalization procedures. The emboli were
observed during imaging of the arterial anastomosis and
the artery distal to the anastomosis, as a filling defect or
abrupt cutoff of the arterial lumen. Symptomatology and
clinical findings including pain, paresthesia, hypothermia,
coldness along the anastomotic distribution of the affected
arterial branch were not noted. Regardless of the presence
or absence of symptoms, 16 of the arterial emboli were
removed using an occlusion balloon (Boston Scientific,
Natick, MA, USA) The balloon was used to retrieve the
emboli from the graft while being inflated and then
retracted in a retrograde manner (3, 4). No additional
complications were encountered during the retraction
process and in all cases, normal flow was re-established in
the artery. In the remaining three cases, one embolus was
removed using a Desilets-Hoffman sheath (Cook,
Bloomington, IN, USA) (Fig. 3), one by surgery, and one
followed up with observation. Graft patency was re-
established allowing successful hemodialysis in all cases. 
Venous Intimal Dissection
A total of 11/3,430 (0.3%) intimal dissections occurred
during the recanalization procedures. They were observed
angiographically as persistent intravenous linear defects
that compromised flow via the vein. All of the cases
occurred during the ballooning. In all 11 cases, the linear
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Fig. 4. 55-year-old man with a left radiocephalic fistula.
A. Extravasation from the distal radial artery is shown.
B. Blood flow is blocked by an angioplasty balloon for five minutes.
C. A follow-up angiography shows no blood leaking. There are no hemodynamically significant complications.
AB Cdefects were ‘tacked up’ against the vein wall by a
prolonged PTA (2 3 min balloon inflation time), with a
successful angiographic result and immediate hemodialysis
in all 11 patients (4).
Graft Rupture-Extravasation During Thrombolysis or
Balloon Dilatation
Graft extravasation from the prior hemodialysis
puncture site was observed in 10/1,662 (0.6%) of graft
recanalizations. Control of this complication was achieved
by light focal digital pressure or by using a balloon
tamponade during the procedure at the site of the extrava-
sation. Special attention is needed in these cases so that the
minimum required distal pressure is applied to control the
extravasation without compromising the flow via the
recanalization graft (4). In this manner, the extravasation
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Fig. 5. 56-year-old woman with a left
upper arm brachiobrachial graft.
A. Tight stenosis at the venous anasto-
mosis (arrow).
B. An angioplasty was attempted, but the
balloon ruptured abruptly.
C. Fragmented balloon is shown in
contrast filled vascular lumen. The
fragmented balloon was removed by
open surgery.
D. Fragmented balloon specimen,
removed.
AB
CDceased and the procedure was completed when graft
patency was established, allowing long-term utilization for
hemodialysis. In extravasation occurred with graft
thrombolysis, firm pressure using an elastic bandage was
applied. No other attempts at treatment of these grafts
were used.
Hematoma and Bleeding
When the only available techniques were purely
pharmacologic, percutaneous thrombolysis resulted in a
large amount of bleeding and perigraft hemorrhage. The
advent of pulse-spray pharmacomechanical thrombolysis
(PMT) and pulse-spray mechanical thrombolysis (MT) with
heparinized saline lowered this rate, but hemorrhagic
complications remain relatively common. For example, the
incidence of bleeding necessitating transfusion was
reported to be 12.9% with pharmacological thrombolysis,
compared to 1.4% with pulse-spray MT (14). Typically
hemorrhage and perigraft hematomas occur at the site
where the needle and sheath were inserted into the arteri-
ovenous graft. In a large series using pulse-spray MT, less
than 3% of the cases were complicated by localized
perigraft hematomas, typically at needle sites.
In our cases, subcutaneous hematomas after urokinase
thrombolysis were observed in 6/102 (5.9%) of the
thrombosed grafts. The hematomas ranged in size from 1
to 3 cm and they did not enlarged during or immediately
following the procedure. The perigraft hematomas were
compressed using an elastic bandage. The graft remained
patent after the initial recanalization without any signs of
hemodynamic insufficiency. They remained stable in size
and well contained without compromising the graft’s
lumen or the normal blood flow in the graft. The grafts
were completely recanalized and then successfully used in
hemodialysis. These patients were monitored clinically for
four weeks following the procedure and complete resolu-
tion or a significant decreased of the hematoma was
observed.
Arterial Dissection and Rupture
In general, the results of angioplasty depend much less
on the number of balloon inflations than on the inflation
pressure and duration. Therefore, as a general rule,
balloons with the lowest possible compliance should be
used. In this way, maximum dilation force with exact
definition of the balloon diameter can be achieved even
with high inflation pressures. Normally, balloon size is
chosen according to the estimated diameter of the nondis-
eased section. As noted earlier, however, some experi-
enced investigators always use slightly oversized (1 or
Kim et al.
192 Korean J Radiol 6(3), September 2005
Fig. 6. 48-year-old woman with a right upper arm brachiojugular graft.
A. Intragraft filling defects means thrombi (arrows).
B. Thrombi aspiration with Desilets-Hoffman sheath was performed. During the procedure the patient experienced chest discomfort and
dyspnea. The final fistulography shows no abnormal filling defect.
C. Perfusion defect is shown in upper left lobe. The patient was managed by conservative treatment with anticoagulant.
AB C2 mm) balloons. The use of a slightly oversized balloon
seems justified as long as inflation pressures do not exceed
4 6 atm; but when high pressures (10 12 atm or more)
are used, it is prudent not to use oversized balloon.
In our group, three cases of four arterial ruptures
(4/3,430, 0.1%) were treated using the same method used
for vein ruptures (Fig. 4). The angioplasty balloon 4 5 mm
in diameter over a 0.035 inch guidewire was inflated to 2
4 atm. Arterial dissections were successfully managed with
conservative treatment.
Balloon Fragmentation
In all three cases of fragmented balloon (3/3,430, 0.1%)
were removed by open surgery (Fig. 5). All cases described
above were identified as fragmented, which resulted in the
retrieval of the balloon by force under incomplete
decompression of the ruptured balloon.
Miscellaneousness
Percutaneous treatment of a thrombosed arteriovenous
graft may lead to the lysed or macerated clot moving
distally into the central venous system, passing through the
right heart into the pulmonary artery, resulting in
pulmonary emboli (PE). Pulmonary embolisms following
percutaneous thrombolysis remain a vexing problem.
Clinically apparent PE occur rarely following these
procedures, but subclinical PE appear to be relatively
common and their long-term effects remain unknown.
There is known to be a large pulmonary vascular reserve,
such that occlusion of 30% or more of the pulmonary
vascular bed is necessary for there to be a significant
hemodynamic effect (15). The volume of the clot that
might be dislodged within the thrombus graft has been
measured to be between 1.6 and 4.7 ml and estimated to
have a maximum volume of 8.4 ml (13), likely much
smaller than would cause a clinically significant pulmonary
embolism. Two points have been raised regarding PE in
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Fig. 7. 29-year-old woman with a left upper arm brachiocephalic
fistula.
A. 20 20 mm-stent migration into superior vena cava is shown
(arrow).
B. 6F-Goose neck snare (arrows) and 5 F-catheter were inserted
into SVC (displaced stent) via a 12 F-sheath of the femoral vein.
C. Guide wire through the 5 F-catheter was snared. The displaced
stent, “Wire-loop” made by pulled Goose neck snare and guide
wire is removed via the femoral vein sheath.
C
ABhemodialysis patients. First, because of the high rate of
graft thrombosis, many patients with arteriovenous grafts
undergo multiple percutaneous thrombolysis procedures.
This potential exposure to recurrent PE may be harmful.
Second, many, if not most, hemodialysis patients have
preexisting cardiopulmonary disease, including pulmonary
hypertension, perhaps rendering them more susceptible to
hemodynamic compromise from iatrogenic PE. The true
incidence of PE following percutaneous thrombolysis of
arteriovenous grafts is unknown, and the incidence may
vary depending on the technique used. Clinical trials of
PMT and MT have reported a low incidence of PE, in the
0 1.0% range (12). In our series of 708 thrombosed HD
access grafts treated by endovascular means, only two
cases of symptomatic pulmonary emboli were observed
(Fig. 6). The two patients were managed by conservative
treatment.
One of the two patients with cardiac arrest due to
hyperkalemia died one day following the procedure. In
patients with chronic renal failure, hyperkalemia is always
associated with hemodialysis failure. Authors check
potassium level and if K+ > 7 mmol/L, start hemodialysis
via central line.
The rate of stent misplacement or migration described in
the literature is very low (2.5% of all procedures).
Management of a displaced stent is successful in 96% of
cases (15). Intravascular stents can migrate into cardiac
cavities or the pulmonary artery when they are deployed
on the venous side. Despite a mean mortality rate of 40%
for patients with a migrated foreign body, it was decided to
abstain from percutaneous therapy after discussions with
the cardiothoracic surgeon and the pneumatologist. The
reasons for this decision were varied and include; the
clinically asymptomatic nature of the pulmonary
embolism; the absence of any signs of pulmonary arterial
hypertension at pulmonary angiography; the absence of
cardiac arrhythmia; the presence of progressive metastatic
disease; the absence of contraindicators for anticoagulants;
the risk of a severe iatrogenic complication in case of an
attempted percutaneous retrieval; and the hazardous
catheterization of the dislodged stent in the right
pulmonary artery. The general opinion is that intravascular
foreign bodies should be removed as soon as possible to
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Fig. 8. 63-year-old man with an infected
graft and stenosis of the venous anasto-
mosis.
A. The patient had a focal infection in the
arterial limb of the graft. Angiography
shows focal stenosis at the venous
anastomosis (arrow).
B. Angioplasty was performed success-
fully. After one day, the patient experi-
enced high fever and petechiae in the
phalanges.
C. After two weeks, multiple nodules
were seen in the periphery of both lung
fields. Yersinia Enterocolitica was
confirmed microbiologically in pleural
effusion and blood.
AB
Cprevent serious complications such as thrombus formation
with a high risk of distal embolization, pulmonary
embolism, sepsis, and endocarditis, and to prevent myocar-
dial or vascular damage leading to severe arrhythmias and
cardiac arrest, perforation of the hemopericardium, and
cardiac tamponade. A major determinant of the
procedure’s success is the selection of the correct stent size.
The diameter of the stent must be greater than that of the
designated vein to prevent stent migration and to compen-
sate neointimal growth. In our displaced stent group (n=2),
one stent was removed by snare (Fig. 7). The other patient
with a displaced stent in the pulmonary artery has received
conservative follow up treatment for five years.
In one septic embolism, the infected graft was removed
surgically (Fig. 8). Hemodialysis patients with prosthetic
vascular access devices, such as polytetrafluoroethylene
(PTFE) grafts are at an increased risk of infection.
Infections are common and the second most common cause
of death, because hemodialsysis patients are in an immuno-
compromised state, have diabetes, or suffer from old age.
Incidence rates of infection are 1 4%/year in native
arteriovenous fistula and 10 20%/year in graft vessels,
with Staphylococcus being the most common microorgan-
ism. This suggests that in our report an impure puncture of
the native arteriovenous fistula is the most likely way for
infections to facilitate, provoking transient invasion of the
bloodstream with bacteria from the local flora.
Consequently, extra care must be given to the skin at the
vascular access site, and patients with dermatitis near or at
the access site should receive antistaphylococcal antibiotic
treatment. In addition, good hand hygiene and wearing a
mask before puncturing provide the best method of
prophylaxis in this context.
In conclusion, this article describes the various complica-
tions that occur during management of HD vascular access
dysfunction and the immediate percutaneous treatment of
these complications can result in relatively high success and
patency rates. It is important to ensure that complications
be monitored on an ongoing basis. These interventional
radiological treatment options contribute significantly to
prolonged access survival and therefore in a better quality
of life for an increasing number of patients undergoing
hemodialysis.
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